EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identifying ICAM-1 as a Therapeutic Target for Cytokine Storm in Human Macrophages Through Integrative Bioinformatics Approaches

Shaojun Chen, Dapeng Wu, Zhe Zheng, Yiyuan Luo, Lihua Zhang

Molecules · 27.03.2026 · 31 (7) · 1111

DOI: 10.3390/molecules31071111 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 27.03.2026. Verfasst von Shaojun Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Chinese Medicine, Zhejiang Pharmaceutical University, Ningbo 315000, China. Hauptthemen laut MEDLINE: Macrophages, Intercellular Adhesion Molecule-1, Computational Biology, Cytokine Release Syndrome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Provincial Basic Public Welfare Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Excessive macrophage activation is thought to be the primary cause of the cytokine storm that results in severe coronavirus disease 2019 (COVID-19) complications. The underlying mechanisms remain elusive, and more research is needed to find disease-critical genes and develop effective therapies. In this study, we used publicly accessible microarray datasets of cytokine storm in cultured human monocyte-derived macrophages challenged with cytokines, and employed bioinformatics, such as weighted gene co-expression network analysis (WGCNA) and differential expression analysis, to dissect gene expression profiles and identify putative disease-related molecules. Initially, three co-expression modules and related key genes were discovered, which highly correlated to macrophages challenged with cytokines. Then, a preliminary gene expression signature consisting of 203 upregulated and 24 downregulated genes was identified. Next, protein–protein interaction analysis and hub gene identification were used to identify 11 crucial hub genes, namely tripartite motif-containing 21 (TRIM21), interferon regulatory factor 1 (IRF1), guanylate binding protein 1 (GBP1), transporter associated with antigen processing 1 (TAP1), nuclear myosin I (NMI), interleukin 15 receptor subunit alpha (IL15RA), apolipoprotein L1 (APOL1), intercellular adhesion molecule 1 (ICAM-1), protein tyrosine phosphatase non-receptor type 1 (PTPN1), E74-like ETS transcription factor 4 (ELF4) and guanylate binding protein 2 (GBP2). Then, the LINCS L1000 characteristic direction signatures search engine (L1000CDS2) was employed for drug repurposing studies. Dasatinib was predicted to be the leading therapeutic compound to perturb the gene signature of cytokine storm in human macrophages. Connectivity Map results suggested that dasatinib may normalize ICAM-1 expression. In addition, the results of molecular docking studies and molecular dynamics simulation revealed that dasatinib may spontaneously interact with ICAM-1 via several key residues and form a relatively stable protein–ligand complex. Overall, this work, based on an analysis of co-expression correlation networks, gene expression signatures and pivotal genes in human macrophages challenged with cytokines, combined with drug repurposing studies, demonstrated that dasatinib may interact with ICAM-1 and could be a potential candidate for cytokine storm. However, due to the limitations of computational approaches, further experimental validation is necessary.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MacrophagesIntercellular Adhesion Molecule-1Computational BiologyCytokine Release SyndromeHumansCOVID-19SARS-CoV-2Gene Expression ProfilingProtein Interaction MapsCytokinesGene Regulatory NetworksGene Expression Regulation

Stichwörter der Autor:innen

COVID-19ICAM-1cytokine stormdasatinibgene expression signatureweighted gene co-expression network analysis

Substanzen

Intercellular Adhesion Molecule-1ICAM1 protein, humanCytokines

Autor:innen und Institutionen

  • Department of Traditional Chinese Medicine, Zhejiang Pharmaceutical University, Ningbo 315000, China.
  • Affiliated Hospital, Nanjing University of Traditional Chinese Medicine, Nanjing 210023, China.
  • School of Pharmacy, Nanjing University of Traditional Chinese Medicine, Nanjing 210023, China.
  • School of Health Management, Zhejiang Pharmaceutical University, Ningbo 315000, China.

Förderung

  • Zhejiang Provincial Basic Public Welfare Research Project

Zitieren

APA

Chen, S., Wu, D., Zheng, Z., Luo, Y., & Zhang, L. (2026). Identifying ICAM-1 as a Therapeutic Target for Cytokine Storm in Human Macrophages Through Integrative Bioinformatics Approaches. Molecules, 31(7), 1111. https://doi.org/10.3390/molecules31071111

Vancouver

Chen S, Wu D, Zheng Z, Luo Y, Zhang L. Identifying ICAM-1 as a Therapeutic Target for Cytokine Storm in Human Macrophages Through Integrative Bioinformatics Approaches. Molecules. 2026;31(7):1111. doi:10.3390/molecules31071111

BibTeX
@article{Chen2026,
  author = {Chen, Shaojun and Wu, Dapeng and Zheng, Zhe and Luo, Yiyuan and Zhang, Lihua},
  title = {Identifying ICAM-1 as a Therapeutic Target for Cytokine Storm in Human Macrophages Through Integrative Bioinformatics Approaches},
  journal = {Molecules},
  year = {2026},
  volume = {31},
  number = {7},
  pages = {1111},
  doi = {10.3390/molecules31071111}
}
Kostenlos starten →